DaVita Options Trading: A Deep Dive into Market Sentiment

Deep-pocketed investors have adopted a bearish approach towards DaVita DVA, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DVA usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for DaVita. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $3,042,421, and 3 are calls, amounting to $249,620.

Projected Price Targets

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $130.0 for DaVita over the last 3 months.

Analyzing Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for DaVita's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of DaVita's whale activity within a strike price range from $120.0 to $130.0 in the last 30 days.

DaVita Call and Put Volume: 30-Day Overview

Noteworthy Options Activity:

About DaVita

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Having examined the options trading patterns of DaVita, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Present Market Standing of DaVita

• With a trading volume of 286,812, the price of DVA is down by 0.0%, reaching $120.89.
• Current RSI values indicate that the stock is may be approaching overbought.
• Next earnings report is scheduled for 74 days from now.

What The Experts Say On DaVita

A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $136.0.

• An analyst from Truist Securities persists with their Hold rating on DaVita, maintaining a target price of $130.
• An analyst from UBS has decided to maintain their Buy rating on DaVita, which currently sits at a price target of $145.
• An analyst from Truist Securities has decided to maintain their Hold rating on DaVita, which currently sits at a price target of $135.
• Maintaining their stance, an analyst from UBS continues to hold a Buy rating for DaVita, targeting a price of $134.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for DaVita, Benzinga Pro gives you real-time options trades alerts.